ANNE FARRELL: Open Payments
NPI 1922561729 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,351 in 113 payments from 30 companies in 2025. Trend: 2023 $485 · 2024 $1,502 · 2025 $2,351
Food & beverage: $2,351
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $305 |
| Biogen, Inc. | 12 | $208 |
| UCB, Inc. | 11 | $193 |
| Vanda Pharmaceuticals Inc. | 7 | $185 |
| PFIZER INC. | 13 | $161 |
| Genentech USA, Inc. | 6 | $140 |
| Eisai Inc. | 1 | $107 |
| Teva Pharmaceuticals USA, Inc. | 4 | $103 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Celgene Corporation | 5 | $97 |
Products named: PONVORY, NURTEC ODT, TYSABRI, QULIPTA, Ocrevus Zunovo, Leqembi, AUSTEDO XR, KESIMPTA.
Industry payments across MO — which companies pay providers there.
